Current status of next-generation vaccines against mpox virus: a scoping review.

Front Pharmacol · 2025 · PMC12066571 · PMID 40356988

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a strong trendno p-value reported

The findings reported thus far on next-generation mpox vaccines, particularly those based on mRNA and recombinant antigens, indicate a strong trend toward conferring high protection against mpox disease.

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.